NCT03502291View on ClinicalTrials.gov

The Effect of Live Attenuated Inactivated Influenza Vaccine on Experimental Human Pneumococcal Carriage Study

PHASE4CompletedINTERVENTIONAL
Enrollment

324

Participants

Timeline

Start Date

August 31, 2015

Primary Completion Date

May 31, 2017

Study Completion Date

May 31, 2017

Conditions
PneumoniaInfluenza, Human
Interventions
BIOLOGICAL

Study one: LAIV + Inoculation

Pneumococci bacteria nasal inoculation following vaccination with LAIV and intramuscular placebo

BIOLOGICAL

Study one: Placebo + Inoculation

Pneumococci bacteria nasal inoculation following vaccination QIV with nasal placebo spray

BIOLOGICAL

Study two: Inoculation + LAIV

Pneumococci bacteria nasal inoculation prior to vaccination with LAIV and intramuscular placebo

BIOLOGICAL

Study two: Inoculation + placebo

Pneumococci bacteria nasal inoculation prior to vaccination QIV with nasal placebo

Trial Locations (1)

L7 8XP

Royal Liverpool Hospital, Liverpool

All Listed Sponsors
collaborator

Sponsor GmbH

OTHER

collaborator

Liverpool School of Tropical Medicine

OTHER

lead

Liverpool University Hospitals NHS Foundation Trust

OTHER_GOV

NCT03502291 - The Effect of Live Attenuated Inactivated Influenza Vaccine on Experimental Human Pneumococcal Carriage Study | Biotech Hunter | Biotech Hunter